PSSJX
Price
$26.85
Change
-$0.02 (-0.07%)
Updated
Jul 31 closing price
Net Assets
1.34B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

PSSJX vs VSCIX

PSSJX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
PSSJX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSSJX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. PSSJX (1.34B). VSCIX pays higher dividends than PSSJX: VSCIX (1.23) vs PSSJX (1.01). PSSJX was incepted earlier than VSCIX: PSSJX (25 years) vs VSCIX (29 years). PSSJX (0.39) is less costly to investors than VSCIX (0.03). PSSJX is a more actively managed with annual turnover of: 35.90 vs. VSCIX (17.00). PSSJX has a lower initial minimum investment than VSCIX: PSSJX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. PSSJX (20.79). VSCIX return over 5 years is better than : 35.13 vs. PSSJX (-6.87).
PSSJXVSCIXPSSJX / VSCIX
Total Expense Ratio0.390.031,300%
Annual Report Gross Expense Ratio0.390.031,300%
Fund Existence25 years29 years-
Gain YTD21.27414.591146%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.34B189B1%
Annual Yield % from dividends1.011.2382%
Returns for 1 year20.7922.5892%
Returns for 3 years16.9643.4439%
Returns for 5 years-6.8735.13-20%
Returns for 10 years31.53156.0720%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C